StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / citryll.com

Citryll

Citryll (citryll.com): 2 changes recorded in its website history since October 2016. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeTargeting the core of inflammatory disorders
    AfterResolving inflammation at its core

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 8 October 2016

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Therapeutic Innovation: targeting neutrophil extracellular traps

Citryll, spun out from ModiQuest is taking a new approach to treat autoimmune diseases like Rheumatoid Arthritis (RA), Colitis and others by extinguishing the source of auto-antigens and neutrophil ex

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. April 2026 – November 2026 · 4 captures · latest observed messagingResolving inflammation at its core

    Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.

    This wording observed 5 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 24 April 2026 · Resolving inflammation at its core archived page
    • 26 August 2026 · Resolving inflammation at its core archived page
    • 26 August 2026 · Resolving inflammation at its core archived page
    • 5 November 2026 · Resolving inflammation at its core current websiteHistorical capture not publicly available
  2. June 2025 – December 2025 · 3 capturesTargeting the core of inflammatory disorders

    Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.

    This wording observed 21 December 2025.

    archived page
    Inspect 3 captures in this group
    • 18 June 2025 · Targeting the core of inflammatory disorders archived page
    • 21 December 2025 · Targeting the core of inflammatory disorders archived page
    • 21 December 2025 · Targeting the core of inflammatory disorders archived page
  3. January 2021 – July 2024 · 4 capturesCitryll – Innovation in Medicine

    This wording observed 18 July 2024.

    archived page
    Inspect 4 captures in this group
    • 21 January 2021 · Citryll – Innovation in Medicine archived page
    • 2 July 2022 · Citryll – Innovation in Medicine archived page
    • 26 September 2023 · Citryll – Innovation in Medicine archived page
    • 18 July 2024 · Citryll – Innovation in Medicine archived page
  4. October 2016 – July 2019 · 4 capturesTargeting the pathobiology of neutrophil extracellular traps

    Citryll, is taking a new approach to treat autoimmune and other human diseases like lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis, by extinguishing the sou

    This wording observed 21 July 2019.

    archived page
    Inspect 4 captures in this group
    • 8 October 2016 · Therapeutic Innovation: targeting neutrophil extracellular traps archived page
    • 11 September 2017 · Therapeutic Innovation: targeting neutrophil extracellular traps archived page
    • 11 August 2018 · Therapeutic Innovation: targeting neutrophil extracellular traps archived page
    • 21 July 2019 · Targeting the pathobiology of neutrophil extracellular traps archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Citryll updates inflammation-focused homepage headline

Citryll has changed its homepage headline wording while keeping an inflammation-related theme and previously added a careers page.

  • Between December 2025 and April 2026, Citryll changed its homepage headline from “Targeting the core of inflammatory disorders” to “Resolving inflammation at its core”. [2]
  • Between July 2019 and January 2021, Citryll added a careers page. [1]
  • Reading: The shift in homepage wording between December 2025 and April 2026 suggests a refinement in how Citryll presents its inflammation-related focus rather than a change in topic. [2]

Cite this record

StartupHistory, “Citryll” company record, https://startuphistory.org/c/citryll.com

Machine-readable: /c/citryll.com.json. How changes are found: method.